Suspension of autologous mononuclear cells separated from bone marrow aspirate

DRUG2 trials

Sponsors

Institute For Clinical And Experimental Medicine

Conditions

chronic limb-threatening ischemiadiabetic foot syndromediabetic foot ulcerslower limb ischemia

Phase 2

A comparison of the effect of autologous bone marrow-derived mononuclear cell therapy with standard treatment on ischemia parameters in diabetic patients with chronic limb-threatening ischemia

RecruitingCTIS2024-519687-40-00

Institute For Clinical And Experimental Medicinediabetic foot syndrome, lower limb ischemia

Start: 2020-09-11Target: 60Updated: 2025-01-13

Efficacy of combined treatment by autologous cell therapy and percutaneous transluminal angioplasty (PTA) versus the treatment by isolated PTA in diabetic patients with chronic limb-threatening ischemia

Not yet recruitingCTIS2024-512873-29-00

Institute For Clinical And Experimental Medicinechronic limb-threatening ischemia, diabetic foot ulcers

Target: 110Updated: 2025-02-25